# Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer

> **NCT00465907** · PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 7 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Paclitaxel, Carboplatin and Irinotecan

## Key facts

- **NCT ID:** NCT00465907
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-05
- **Primary completion:** 2008-03
- **Final completion:** 2014-02
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2019-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465907, "Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00465907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*